Zheng Su

Private Equity Investor chez Deerfield Management Co. LP (Private Equity)

Profil

Zheng Su, Ph.D., is a Partner on the Therapeutics team.
Between 2013 and 2021, Dr. Su spent over eight years at Deerfield in roles of increasing responsibility.
Following a brief absence, he returned to the Firm in 2022.
Prior to Deerfield, he was a Senior Statistical Scientist at Genentech, an Assistant Professor at SUNY Stony Brook, and a Visiting Assistant Professor at Stanford University.
He was formerly Editor-in-Chief of Contemporary Clinical Trials and Co-Editor-in-Chief of Contemporary Clinical Trials Communications.
Dr. Su holds a B.S.
in Mathematics from Peking University, as well as an M.S.
in Financial Mathematics and a Ph.D.
in Computational Mathematics and Statistics from Stanford University, where he also received his post-doctoral training in biostatistics.
He has published over 50 articles on the design and analysis of clinical trials.

Postes actifs de Zheng Su

Sociétés	Poste	Début
Deerfield Management Co. LP (Private Equity)	Private Equity Investor	01/01/2013

Formation de Zheng Su

Peking University	Undergraduate Degree
Stanford University	Doctorate Degree